|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
10/22/2024
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
References: Public disclosures on 10/16/2019, 02/17/2021, 10/22/2021, 01/17/2022, 10/03/2022, 04/20/2023, 05/02/2024 and 10/22/2024. As is known, in the process regarding Halkbank's ongoing criminal case in the USA; the Second Circuit with its decision dated October 22, 2024, had rejected our Bank's common law immunity request and affirmed the District Court's order. Regarding the Second Circuit's decision dated October 22, 2024; our Bank filed its petition for a writ of certiorari with the U.S. Supreme Court on May 5, 2025, which includes Halkbank's arguments concerning common law sovereign immunity. For the information of the public and investors. In case of any contradiction between the Turkish and English versions of this public disclosure, the Turkish version shall prevail. |
||||||||